California State Teachers Retirement System Kala Pharmaceuticals, Inc. Transaction History

California State Teachers Retirement System

$84.1 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.3 - $1.31 $6,399 - $27,943	-21,331 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.61 - $1.84 $2,860 - $8,627	-4,689 Reduced 18.02%	21,331 $29,000
Q4 2021 Feb 15, 2022	SELL	$1.16 - $2.74 $41,024 - $96,902	-35,366 Reduced 57.61%	26,020 $31,000
Q3 2021 Nov 15, 2021	SELL	$2.62 - $5.43 $13,639 - $28,268	-5,206 Reduced 7.82%	61,386 $161,000
Q2 2021 Aug 16, 2021	BUY	$5.06 - $8.15 $34,989 - $56,357	6,915 Added 11.59%	66,592 $353,000
Q2 2020 Aug 17, 2020	BUY	$8.33 - $13.79 $196,779 - $325,761	23,623 Added 65.52%	59,677 $627,000
Q1 2020 May 13, 2020	BUY	$3.83 - $8.79 $9,310 - $21,368	2,431 Added 7.23%	36,054 $317,000
Q2 2019 Aug 14, 2019	BUY	$4.93 - $8.8 $43,344 - $77,369	8,792 Added 35.41%	33,623 $215,000
Q1 2019 May 09, 2019	BUY	$5.19 - $8.97 $8,682 - $15,006	1,673 Added 7.22%	24,831 $205,000
Q4 2018 Feb 13, 2019	BUY	$4.29 - $9.94 $22,917 - $53,099	5,342 Added 29.98%	23,158 $113,000
Q2 2018 Aug 14, 2018	SELL	$13.3 - $17.49 $52,003 - $68,385	-3,910 Reduced 18.0%	17,816 $245,000
Q1 2018 May 15, 2018	BUY	$12.26 - $18.98 $111,014 - $171,863	9,055 Added 71.46%	21,726 $344,000
Q4 2017 Feb 14, 2018	SELL	$13.68 - $23.17 $7,236 - $12,256	-529 Reduced 4.01%	12,671 $234,000
Q3 2017 Nov 13, 2017	BUY	$19.86 - $26.53 $262,152 - $350,196	13,200	13,200 $301,000

Others Institutions Holding KALA

# of Institutions

Shares Held

Call Options Held

Put Options Held

Parallel Advisors, LLC

1
Shares

$6
0.0% of portfolio

View Full List

About Kala Pharmaceuticals, Inc.

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $10.2M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

More about KALA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account